SCHEMBL16631586

SCHEMBL16631586

O=c1ccc([C@H]2C[C@@H](O)[C@@H](CO)O2)c(F)[nH]1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ALOX12 P18054 1/20 0.41
ADRA1A P35348 1/20 0.41
TK1 P04183 3/20 0.38
NCOA1 Q15788 1/20 0.37
NCOA3 Q9Y6Q9 1/20 0.37
SLC28A1 O00337 1/20 0.36
SLC28A2 O43868 1/20 0.36
SLC29A1 Q99808 1/20 0.36
SLC28A3 Q9HAS3 1/20 0.36
TK2 O00142 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16631724 0.79 LMNA (0.42) LMNASMN1; SMN2ALOX12ADRA1ATK1
SCHEMBL16631618 0.76 LMNA (0.44) LMNASMN1; SMN2ALOX12ADRA1ATK1
SCHEMBL16781789 0.75 SLC28A1 (0.46) SLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL18852567 0.75 SLC28A1 (0.46) SLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL18871319 0.75 SLC28A1 (0.46) SLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL16781790 0.75 SLC28A1 (0.46) SLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL16631263 0.75 SLC28A1 (0.46) SLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL16805391 0.75 SLC28A1 (0.46) SLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL16631525 0.73 SLC28A1 (0.41) SLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL17384497 0.72 TK1 (0.37) LMNASMN1; SMN2ALOX12ADRA1ATK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015196130-A2 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF MODERNA THERAPEUTICS, INC. (US) 2015-12-23 WO disclosed
WO-2015051173-A2 POLYNUCLEOTIDE MOLECULES AND USES THEREOF MODERNA THERAPEUTICS, INC (US) 2015-04-09 WO disclosed